☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
bms
BMS’ Krazati Receives the US FDA’s Accelerated Approval to Treat Locally Advanced or Metastatic Colorectal Cancer (mCRC)
June 25, 2024
BMS Reports the EMA’s Validation of the Application for Subcutaneous Opdivo
June 21, 2024
BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors
June 14, 2024
BMS Features the P-III (CheckMate -9DW) Trial Data of Opdivo Plus Yervoy for Treating Advanced Hepatocellular Carcinoma at ASCO 20...
June 5, 2024
BMS Highlights Data from three P-III Studies of Breyanzi to Treat Various B-Cell Malignancies at ASCO 2024
June 4, 2024
BMS Reports the US FDA’s Approval of Breyanzi for Treating Mantle Cell Lymphoma
May 31, 2024
Load more...
Back to Home